Quince Therapeutics

About:

Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.

Website: https://quincetx.com/

Twitter/X: cortexyme

Top Investors: Pfizer, Verily, Sequoia Capital, Breakout Ventures, Takeda Ventures

Description:

Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.